These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7151472)

  • 1. Vasodilator drug therapy in congestive heart failure.
    Badke FR; O'Rourke RA
    Curr Probl Cardiol; 1982 Nov; 7(8):1-42. PubMed ID: 7151472
    [No Abstract]   [Full Text] [Related]  

  • 2. [Long-term vasodilator therapy for chronic congestive heart failure: is it effective?].
    Yasuda H; Obata H
    Kokyu To Junkan; 1985 Mar; 33(3):241-5. PubMed ID: 3892610
    [No Abstract]   [Full Text] [Related]  

  • 3. Rationale and use of vasodilators in the management of congestive heart failure.
    Lakier JB; Khaja F; Stein PD
    Am Heart J; 1979 Apr; 97(4):519-26. PubMed ID: 371379
    [No Abstract]   [Full Text] [Related]  

  • 4. Vasodilator therapy for congestive heart failure.
    Fouad FM
    Cardiovasc Clin; 1981; 12(2):127-35. PubMed ID: 7344769
    [No Abstract]   [Full Text] [Related]  

  • 5. [Responses to vasodilator therapy in patients with congestive heart failure].
    Guo HY
    Sheng Li Ke Xue Jin Zhan; 1984 Jan; 15(1):30-4. PubMed ID: 6515395
    [No Abstract]   [Full Text] [Related]  

  • 6. [Acute heart failure and vasodilator therapy].
    Sekiguchi M; Hiroe M; Osamura Y; Take M
    Nihon Rinsho; 1978 Nov; 36(11):3554-64. PubMed ID: 104067
    [No Abstract]   [Full Text] [Related]  

  • 7. [Vasodilator therapy of heart failure].
    Mathey D
    Dtsch Med Wochenschr; 1979 Apr; 104(16):563-4. PubMed ID: 108068
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of vasodilators in managing congestive heart failure.
    Franciosa JA
    Postgrad Med; 1980 Jan; 67(1):87-91, 94-8. PubMed ID: 6765989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Vasodilators in heart failure. Basis for their use].
    Mesquita ET; Mady C
    Arq Bras Cardiol; 1994 Dec; 63(6):531-6. PubMed ID: 7605242
    [No Abstract]   [Full Text] [Related]  

  • 10. Vasodilator therapy for decompensated heart failure.
    Yancy CW
    J Am Coll Cardiol; 2008 Jul; 52(3):208-10. PubMed ID: 18617069
    [No Abstract]   [Full Text] [Related]  

  • 11. Vasodilators have not been shown to be of value in all patients with chronic congestive heart failure due to left ventricular systolic dysfunction.
    Kulick DL; Rahimtoola SH
    Am J Cardiol; 1990 Aug; 66(4):435-8. PubMed ID: 2201177
    [No Abstract]   [Full Text] [Related]  

  • 12. [Significance of vasodilator agents in the treatment of heart insufficiency].
    Fischer E
    Schweiz Med Wochenschr; 1982 May; 112(19):684-8. PubMed ID: 7100867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Milrinone: a positive inotropic vasodilator.
    Colucci WS; Jaski BE; Fifer MA; Wright RF; Braunwald E
    Trans Assoc Am Physicians; 1984; 97():124-33. PubMed ID: 6535335
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of the calcium antagonist felodipine as supplementary vasodilator therapy in patients with chronic heart failure treated with enalapril: V-HeFT III. Vasodilator-Heart Failure Trial (V-HeFT) Study Group.
    Cohn JN; Ziesche S; Smith R; Anand I; Dunkman WB; Loeb H; Cintron G; Boden W; Baruch L; Rochin P; Loss L
    Circulation; 1997 Aug; 96(3):856-63. PubMed ID: 9264493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flosequinan, a new vasodilator: systemic and coronary hemodynamics and neuroendocrine effects in congestive heart failure.
    Cavero PG; De Marco T; Kwasman M; Lau D; Liu M; Chatterjee K
    J Am Coll Cardiol; 1992 Dec; 20(7):1542-8. PubMed ID: 1452928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonparenteral vasodilator therapy for chronic congestive heart failure.
    Chatterjee K; Brundage BH; Ports TA
    Compr Ther; 1979 Nov; 5(11):48-55. PubMed ID: 116798
    [No Abstract]   [Full Text] [Related]  

  • 17. Vasodilators in the management of acute heart failure.
    Elkayam U; Janmohamed M; Habib M; Hatamizadeh P
    Crit Care Med; 2008 Jan; 36(1 Suppl):S95-105. PubMed ID: 18158484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasodilator therapy in cardiac failure what was new is old.
    O'Rourke MF; Nichols WW
    J Am Coll Cardiol; 2009 Mar; 53(10):898; discussion 898-99. PubMed ID: 19264253
    [No Abstract]   [Full Text] [Related]  

  • 19. Modern management of heart failure.
    Davies MK
    Br J Hosp Med; 1992 Jan 9-22; 47(1):16-8, 20-2, 24. PubMed ID: 1737187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pimobendan has a potent venodilating action in patients with congestive heart failure.
    Matsumoto A; Momomura S; Yokoyama I; Aoyagi T; Sugiura S; Omata M
    Cardiovasc Drugs Ther; 1998 Dec; 12(6):595-7. PubMed ID: 10410829
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.